Production (Stage)
Castle Biosciences, Inc.
CSTL
$16.10
$0.211.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -6.13% | 4.77% | 7.74% | 8.56% | -1.60% |
| Total Receivables | 11.20% | 1.90% | 9.29% | 7.70% | 11.48% |
| Inventory | -15.81% | 23.78% | -17.98% | 4.81% | -3.74% |
| Prepaid Expenses | 36.03% | -5.92% | 21.41% | 7.96% | -1.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -2.99% | 4.46% | 7.61% | 8.33% | 0.05% |
|
|
|||||
| Total Current Assets | -2.99% | 4.46% | 7.61% | 8.33% | 0.05% |
| Net Property, Plant & Equipment | 6.19% | 11.40% | 11.99% | 12.02% | 18.88% |
| Long-term Investments | 0.00% | 0.00% | 0.01% | -0.01% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.01% | -0.01% | 0.00% |
| Total Other Intangibles | -29.65% | -4.35% | -2.22% | -2.15% | -2.11% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.59% | -26.93% | -22.87% | 37.18% | 5.51% |
| Total Assets | -5.56% | 3.24% | 5.59% | 6.28% | 1.14% |
|
|
|||||
| Total Accounts Payable | 23.20% | 1.34% | -28.62% | 2.38% | -9.25% |
| Total Accrued Expenses | -38.57% | 10.25% | 26.56% | 34.07% | -41.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 24.56% | 17.13% | 42.33% | 3.11% | -1.57% |
| Total Finance Division Other Current Liabilities | 40.19% | 173.28% | -32.98% | 24.67% | -18.16% |
| Total Other Current Liabilities | 40.19% | 173.28% | -32.98% | 24.67% | -18.16% |
| Total Current Liabilities | -24.53% | 11.51% | 12.27% | 23.45% | -32.95% |
|
|
|||||
| Total Current Liabilities | -24.53% | 11.51% | 12.27% | 23.45% | -32.95% |
| Long-Term Debt | -8.46% | -2.70% | 0.07% | 0.08% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.90% | -2.16% | 7.33% | 0.55% | -2.24% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -47.92% | -61.92% | -- | -- | 0.00% |
| Total Liabilities | -18.56% | 2.57% | 15.91% | 13.16% | -9.71% |
|
|
|||||
| Common Stock & APIC | 1.59% | 0.84% | 2.24% | 2.02% | 2.29% |
| Retained Earnings | -12.92% | 4.57% | 1.07% | 4.04% | -1.16% |
| Treasury Stock & Other | -43.04% | -51.37% | 375.00% | -54.95% | -181.62% |
| Total Common Equity | -3.41% | 3.35% | 4.05% | 5.32% | 2.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.41% | 3.35% | 4.05% | 5.32% | 2.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.41% | 3.35% | 4.05% | 5.32% | 2.86% |
|
|
|||||